We are focused on improving the lives of patients suffering from pain and their caregivers through the development of novel, targeted medications.
In the United States, widespread use of opioids has led to an epidemic of opioid abuse and misuse with severe healthcare consequences. Our primary focus lies in the development of non-opioid products for meeting the needs of underserved patients with pain conditions. We are actively developing multiple clinical-stage programs that address significant patient needs in low back pain and cancer pain. Both approaches represent novel and targeted non-opioid treatments.